1.Frusemide plus doxazosin therapy for nocturia in patients with BPH/LUTS.
Shi-yong HUANG ; Shao-xing ZHU ; Bang-wei ZENG ; De-sheng ZHU ; Rong-jin FANG
National Journal of Andrology 2010;16(9):807-810
OBJECTIVETo determine the efficacy and safety of a diuretic agent, frusemide, combined with doxazosin in the treatment of nocturia in patients with benign prostate hyperplasia / lower urinary tract symptoms (BPH/LUTS).
METHODSSixty-four BPH/LUTS patients with nocturia were equally randomized into two groups, one treated with doxazosin (4 mg/d), and the other with frusemide (40 mg/d) and doxazosin (4 mg/d), given 6 h before sleep, both for 4 weeks. Urine volume, IPSS, QOL, serum electrolytes, plasma osmolality were recorded and compared between the two groups before and after the treatment.
RESULTSCompared with the doxazosin group, the frusemide plus doxazosin group showed significantly reduced nocturia frequency (P < 0.01), increased daytime urine output (P < 0.01), decreased nocturia urine output (P < 0.01), unchanged total urine output (P > 0.05), improved IPSS and QOL (P < 0.05, P < 0.01), but with no remarkable differences in the levels of serum sodium, potassium, chlorine, and osmotic pressure (P > 0.05).
CONCLUSIONFour-week treatment with frusemide plus doxazosin was safe and effective for nocturia in patients with BPH/LUTS.
Aged ; Aged, 80 and over ; Doxazosin ; therapeutic use ; Furosemide ; therapeutic use ; Humans ; Male ; Middle Aged ; Nocturia ; drug therapy ; etiology ; Prostatic Hyperplasia ; complications ; drug therapy
2.Correlation of Skp2 overexpression to prognosis of patients with nasopharyngeal carcinoma from South China.
Hui-Min XU ; Yi LIANG ; Qiong CHEN ; Qi-Nian WU ; Yun-Miao GUO ; Guo-Ping SHEN ; Ru-Hua ZHANG ; Zhi-Wei HE ; Yi-Xin ZENG ; Fang-Yun XIE ; Tie-Bang KANG
Chinese Journal of Cancer 2011;30(3):204-212
S-phase kinase-associated protein 2 (Skp2), which plays a role in cell cycle regulation, is commonly overexpressed in a variety of human cancers and associated with poor prognosis. However, its role in nasopharyngeal carcinoma (NPC) is not well understood. In this study, we examined the clinical significance of Skp2, with a particular emphasis on overall survival (OS) and disease-free survival (DFS), in NPC cases in South China, where NPC is an epidemic. Additionally, we explored the function of Skp2 in maintaining a cancer stem cell-like phenotype in NPC cell lines. Skp2 expression was assessed for 127 NPC patients using tissue microarrays and immunohistochemistry and analyzed together with clinicopathologic features, OS, and DFS. Skp2 expression was detectable, or positive, in 75.6% of patients. Although there was no correlation between Skp2 and any clinicopathologic factor, Skp2 expression significantly portended inferior OS (P = 0.013) and DFS (P = 0.012). In the multivariate model, Skp2 expression remained significantly predictive of poor OS [P = 0.009, risk ratio (RR) = 4.06] and DFS (P = 0.008, RR = 3.56), and this was also true for clinical stage (P = 0.012 and RR=3.201 for OS; P = 0.002 and RR=1.94 for DFS) and sex (P = 0.016 and RR=0.31 for OS; P = 0.006 and RR = 0.27 for DFS). After Skp2 knockdown, a colony formation assay was used to evaluate the self-renewal property of stem-like cells in the NPC cell lines CNE-1 and CNE-2. The colony formation efficiency in CNE-1 and CNE-2 cells was decreased. In Skp2-transfected CNE-1 and CNE-2 cells, side population (SP) proportion was increased as detected by flow cytometry. Skp2 is an independent prognostic marker for OS and DFS in NPC. Skp2 may play a role in maintaining the cancer stem cell-like phenotype of NPC cell lines.
Adolescent
;
Adult
;
Aged
;
Carcinoma
;
Cell Line, Tumor
;
China
;
Disease-Free Survival
;
Female
;
Follow-Up Studies
;
Gene Knockdown Techniques
;
Humans
;
Male
;
Middle Aged
;
Nasopharyngeal Neoplasms
;
genetics
;
metabolism
;
pathology
;
Neoplasm Staging
;
Neoplastic Stem Cells
;
pathology
;
RNA, Small Interfering
;
genetics
;
S-Phase Kinase-Associated Proteins
;
genetics
;
metabolism
;
Sex Factors
;
Survival Rate
;
Tissue Array Analysis
;
Transfection
;
Young Adult
3.Giant pathologic section in the study of optimal length of surgical resection for esophageal carcinoma.
Guo-wei MA ; Tie-hua RONG ; Qiu-liang WU ; Hao LONG ; Jian-hua FU ; Peng LIN ; Zhi-fan HUANG ; Can-guang ZENG ; Xiao-dong LI ; Xu ZHANG ; Lan-jun ZHANG ; Jun-ye WANG ; Yi HU ; Bang-fa DENG
Chinese Journal of Oncology 2003;25(5):472-474
OBJECTIVETo study the optimal surgical resection length for esophageal carcinoma.
METHODSSpecimens of seventy patients with esophageal squamous cell carcinoma resected and collected in our hospital were made into pathologic giant sections. Direct intramural infiltration, multicentric carcinogenic lesion and leaping metastasis were observed in the large slice by microscope. The actual length during the operation was calculated by the ratio of shrinkage.
RESULTSDirect intramural infiltration was found in 51 (72.9%) patients, 39 proximal and 36 distal to the tumor. The mean length of direct intramural infiltration was 0.9 +/- 0.8 cm (4.0 cm maximum) proximally and 0.5 +/- 0.3 cm (2.0 cm maximum) distally. Multicentric carcinogenic lesion was found in 11 (15.7%) patients, 5 proximally, 8 distally and 2 on both sides. Proximal to the tumor, the mean distance between the multicentric carcinogenic lesion and the main lesion plus the length of the multiple carcinogenic lesion was 3.2 +/- 1.5 cm (4.7 cm maximum). Distal to the tumor, it was 3.6 +/- 2.4 cm (9.1 cm maximum). Leaping metastasis was found in 9 (12.9%) patients, 7 proximally and 4 distally. The mean distance between the leaping metastasis and the main lesion plus the length of the leaping metastatic lesion was 1.9 +/- 0.6 cm (2.9 cm maximum) proximally and 1.4 +/- 1.0 cm (2.7 cm in maximum) distally.
CONCLUSIONThe optimal surgical resection length for esophageal carcinoma should be at least 5 cm proximal to the tumor and total length on the distal side.
Esophageal Neoplasms ; pathology ; surgery ; Female ; Humans ; Male ; Neoplasm Invasiveness
4. Analysis on comparison of inter-laboratory results of chemical volatile organic compounds
Rui-bo MENG ; Wei-feng RONG ; Ai-hua ZHANG ; Fei-fei ZENG ; Jia-wei HU ; Bang-hua WU
China Occupational Medicine 2021;48(02):167-170
OBJECTIVE: To analyze the comparison results of volatile organic components in chemicals tested by occupational health laboratories.METHODS: A total of 37 reference laboratories that participated in the 2019 National Occupational Health Inspection and Testing Institution Laboratory Comparison Chemical Qualitative Testing Comparison organized by Guangdong Occupational Health Testing Center were selected as the research subjects. Headspace gas chromatography-mass spectrometry was used for the determination of volatile organic components in chemicals. The comparison results of reference laboratories were collected and implemented with qualitative and quantitative evaluation. RESULTS: The qualified rates of the qualitative results of the required hazard factors and other hazard factors in the reference laboratories were higher than those of the quantitative results of similar factors with statistical significance(83.78% vs 67.57%, 89.19% vs 56.76%, all P<0.05). There was no significant difference in the qualified rate of qualitative and quantitative results and comprehensive judgment results among each reference laboratory with other hazard factors(83.78% vs 89.19%, 67.57% vs 56.76%, 83.78% vs 89.19%, all P>0.05). The qualified rate of 37 reference laboratories was 89.19%(33/37). It showed no significant difference in the qualified rate of qualitative, quantitative and comprehensive judgment results among the reference laboratories of disease prevention and control system and non-disease prevention and control system(93.75% vs 85.72%, 85.00% vs 61.91%, 93.75% vs 85.52%,all P>0.05). CONCLUSION: There are great differences in the detection ability of volatile organic components on chemicals of each reference laboratory. The ability of qualitative detection is superior to the quantitative detection.